Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

NCT00038636 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00038636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00038636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2000
Completion date
Not reported
Enrollment
36
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections